Deloitte's NextGen Therapies Industry Working Group (IWG) is a forum where advanced therapy leaders come together to address the challenges affecting patient access to transformational therapies - sharing best practice and working towards solutions that benefit the whole field.

The Managing Partner, Sean Russell, will be participating in the panel discussion Commercializing Advanced Therapies in EMEA: Regulatory Requirements & Go To Market Strategy at the 4th EMEA IWG meeting in Rome, Italy on April 26–27.

Please get in touch with Sean or the PrimeRA Pharma Partners team if you are attending and would like to arrange a meeting.